Market Closed

KZIA
Kazia Therapeutics Limited
$ 6.62
-4.75%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Kazia Therapeutics Limited News

Latest Kazia Therapeutics Limited Stock News & KZIA Headlines

Novogen Limited (NASDAQ:KZIA) Stock Has Consensus Price Target of $29.50
5 days ago | defenseworld.net
Kazia Therapeutics Recognized as "Drug Discovery Company of the Year" in 2026 BioTech Breakthrough Awards
11 days ago | prnewswire.com
Kazia Therapeutics Announces Two Abstracts on Paxalisib Tumor and Immune Reprogramming Research Accepted for Poster Presentation at 2026 San Antonio Breast Cancer Symposium
14 days ago | prnewswire.com
Kazia Therapeutics to Participate in Fireside Chat at Guggenheim 3rd Annual Healthcare Innovation Conference
18 days ago | prnewswire.com
Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders
2 months ago | prnewswire.com
Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer
2 months ago | prnewswire.com
Kazia Therapeutics Limited (KZIA) Discusses Clinical and Corporate Updates With Focus on Paxalisib Programs in Breast and Colorectal Cancer Transcript
2 months ago | seekingalpha.com
Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer
2 months ago | prnewswire.com
Kazia Therapeutics Limited Announces Oversubscribed Closing of Up to $120 Million Public Offering
3 months ago | prnewswire.com
Kazia Therapeutics: Worth Speculating On Paxalisib's TNBC Data
3 months ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

KZIA
Kazia Therapeutics Limited
$ 6.62
-4.75%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago